| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/10/2006 | EP1035860B1 Non-toxic immune stimulating enterotoxin compositions |
| 05/10/2006 | EP1015026B1 Il-12 as an adjuvant for bordetella pertussis vaccines |
| 05/10/2006 | EP1003548B1 Device for inducing a ctl response |
| 05/10/2006 | EP0972055B1 METHOD FOR PRODUCING PURIFIED AND MARKED TSH RECEPTOR PREPARATIONS AND THE USE OF the corresponding PREPARATIONS IN DIAGNOSTICS |
| 05/10/2006 | EP0960129B1 MELATONIN 1a RECEPTOR GENE REGULATORY REGIONS AND USES THEREOF |
| 05/10/2006 | EP0809700B1 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 05/10/2006 | EP0790062B1 Method of testing for myocarditis and cariomyopathy |
| 05/10/2006 | EP0721505B2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 05/10/2006 | CN1771329A The use of PDE4D in the screening for medicaments against atherosclerosis |
| 05/10/2006 | CN1771325A Compounds and their use for specific and simultaneous inhibition of genes involved in diseases and related drugs |
| 05/10/2006 | CN1771259A Antitumor effect of mutant bik |
| 05/10/2006 | CN1771057A Releasable polymeric conjugates based on biodegradable linkers |
| 05/10/2006 | CN1771054A Improved vaccines |
| 05/10/2006 | CN1771052A Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
| 05/10/2006 | CN1771051A Skin collagen production promoter |
| 05/10/2006 | CN1771050A Macrocyclic hepatitis c serine protease inhibitors |
| 05/10/2006 | CN1771049A Somatostatin-dopamine chimeric analogs |
| 05/10/2006 | CN1771040A Remedy for diabetes. |
| 05/10/2006 | CN1769456A Recombinant a human peptide production method |
| 05/10/2006 | CN1769298A Fusion protein with antitumour action and its coding gene and uses |
| 05/10/2006 | CN1769274A Pyrazinone protease inhibitors |
| 05/10/2006 | CN1768873A Apparatus for electroporation mediated delivery for drugs and genes |
| 05/10/2006 | CN1768858A Composition and method for repairing nerve damage and enhancing functional recovery of nerve |
| 05/10/2006 | CN1768855A Medicine for treating cervical carcinoma, its preparation process and application |
| 05/10/2006 | CN1255552C Method for using human CRYGS gene and its coded products to diagnose and treat lesion of crystalline lens |
| 05/10/2006 | CN1255548C Acetylation of GP41 framgnets |
| 05/10/2006 | CN1255543C Expression and application of transduction peptides - human insulinogen fusion protein |
| 05/10/2006 | CN1255542C Constructing genetic engineering Vaccine of adhesin of confluent Helicobacter pylor and preparation method |
| 05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
| 05/10/2006 | CN1255428C Template-fixed peptidomimetics with antimicrobial activity |
| 05/10/2006 | CN1255427C Method and composition for treating liver cell cancer |
| 05/10/2006 | CN1255426C Peptides for treatment of erectile dysfunction |
| 05/10/2006 | CN1255392C Colchinol derivatives as angiogenesis inhibitors |
| 05/10/2006 | CN1255185C Pharmaceutical dosage form of amorphous nelfinavir mesylate |
| 05/10/2006 | CN1255184C Application of glucose-insulin-potassium polarization liquid in preparation of medicine for treating trauma and burn |
| 05/10/2006 | CN1255183C Myocardium peptide and its use |
| 05/10/2006 | CN1255182C Thymic peptide infusion and preparation process |
| 05/09/2006 | US7041836 Antibiotic compounds |
| 05/09/2006 | US7041817 Purification of preferential nucleotide sequences; obtain nucleotide sequences, load onto column, elute, deprotect, load deprotected mixture onto column, elute and recover sequences |
| 05/09/2006 | US7041808 an agricultural, pharmaceutical or industrial microbiocidal mixture using the thermotolerant, antimicrobial protein as the active ingedient |
| 05/09/2006 | US7041803 Galectin 11 |
| 05/09/2006 | US7041802 Peptidoglycan recognition proteins |
| 05/09/2006 | US7041800 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 05/09/2006 | US7041799 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 05/09/2006 | US7041797 dissecting a silkworm, removing the gland without contamination from the silkworm body fluids, extracting the silk feedstock solution, crosslinking with an aldehyde; extrusion, molding or spinning; fibroin protein fibers with improved mechanical properties |
| 05/09/2006 | US7041796 C3b/C4b Complement Receptor-like molecules and uses thereof |
| 05/09/2006 | US7041795 Potassium channel interacting polypeptides and uses thereof |
| 05/09/2006 | US7041794 Nucleotide sequence comprises at least one new SNP (single nucleotide polymorphism) |
| 05/09/2006 | US7041790 Fibrinogen binding moieties |
| 05/09/2006 | US7041789 RFRP-3 and DNA thereof |
| 05/09/2006 | US7041788 Multimerized highly functional antifreeze protein |
| 05/09/2006 | US7041787 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases |
| 05/09/2006 | US7041786 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 05/09/2006 | US7041785 for treatment of inflammation, diabetic vasculopathy; enzyme resistance |
| 05/09/2006 | US7041784 Apoptotic compounds |
| 05/09/2006 | US7041698 Tripeptide analogs that inhibit the functioning of the NS3 protease encoded by Hepatitis C virus |
| 05/09/2006 | US7041655 hydroxyethyl starch or dextran and superoxide dismutase, glutathione peroxidase, catalase, hydroxyethyl rutoside, cyclic adenosine monophosphate or vitamin C; prevents the harmful effect of free radicals on cellular membranes and other organelles during a period of increased capillary permeability |
| 05/09/2006 | US7041653 Gene transcription and ionizing radiation: methods and compositions |
| 05/09/2006 | US7041649 Embodiments of the present invention relate to administering cephaibols to treat conditions of the nervous system and to treat those conditions in which suppressing the immune system would have beneficial effect. |
| 05/09/2006 | US7041648 Compositions and methods for treating female fertility |
| 05/09/2006 | US7041647 having the amino acid sequence: VAPIAKYLATALAKWALKQGFAKLKS and pharmaceutically acceptable salts or derivatives; may be in a form suitable for oral, topical, rectal or parenteral administration or in a form suitable for agricultural use |
| 05/09/2006 | US7041646 Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists |
| 05/09/2006 | US7041645 Methods of inhibiting or inducing bone formation |
| 05/09/2006 | US7041644 Administering BPI protein product effective to alleviate the BPI deficiency |
| 05/09/2006 | US7041643 Controlling apoptosis; antiinflammatory agents |
| 05/09/2006 | US7041642 Fluorescent bombesin-like peptides |
| 05/09/2006 | US7041641 Kit comprising osteogenic protein, matrix derived from nonsynthetic, nonpolymeric material, and binding agent for induction of local bone or cartilage formation |
| 05/09/2006 | US7041640 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 05/09/2006 | US7041639 Depsipeptide and congeners thereof for use as immunosuppressants |
| 05/09/2006 | US7041638 Surfactant prevention of vaginitis and lung complications from cancer chemotherapy |
| 05/09/2006 | US7041637 Echinocandin/carbohydrate complexes |
| 05/09/2006 | US7041636 menthol solution combined with Polysorbate 80 or 60, isopropyl alcohol and lupine protein, with the optional addition of petroleum jelly as a thickener |
| 05/09/2006 | US7041635 Factor VIII polypeptide |
| 05/09/2006 | US7041634 Method of inhibiting immune system destruction of transplanted viable cells |
| 05/09/2006 | US7041506 Fibronectins; fibroblast growth factors |
| 05/09/2006 | US7041504 Cancer cell-inhibiting culture medium produced by culturing restricted entrapped cancer cells |
| 05/09/2006 | US7041503 Modified myelin basic protein molecules |
| 05/09/2006 | US7041502 Immunology active materials; complexing to major histocompatibility complex |
| 05/09/2006 | US7041497 Used in regulation of genes for tissue inflammation, cellular proliferation, differentiation |
| 05/09/2006 | US7041495 nucleotide sequence encoding PNCK that is temporally expressed during postnatal mammary development in a spatially heterogeneous manner in certain subsets of cells, and overexpressed in a subset of primary breast cancers; used as prognostic tools, screening tools and in therapies |
| 05/09/2006 | US7041487 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 05/09/2006 | US7041478 Polypeptide for use in the treatment cancer, inflammation of autoimmune disorders |
| 05/09/2006 | US7041475 Transport protein for use in human therapeutics and diagnostics |
| 05/09/2006 | US7041474 Nucleic acid encoding human tango 509 |
| 05/09/2006 | US7041465 Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof |
| 05/09/2006 | US7041460 Antibodies to monocyte-colony inhibitory factor (M-CIF) |
| 05/09/2006 | US7041454 Genomic sequence of the purH gene and purH-related biallelic markers |
| 05/09/2006 | US7041442 peptides or derivatives of the 65 kD lower matrix phoshpoprotein of HCMV useful for determining whether subjects have been exposed to the virus and for determining the peptide-induced production of interferon- gamma and/or TNF- alpha in CD8+ T cells isolated from subjects |
| 05/09/2006 | US7041440 IP3-binding polypeptides and methods of using them |
| 05/09/2006 | US7041437 Genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions. |
| 05/09/2006 | US7041314 GPE analogs and peptidominetics |
| 05/09/2006 | US7041312 Wound healing compositions and methods of use |
| 05/09/2006 | US7041302 Therapeutic modulation of the tumor inflammatory response |
| 05/09/2006 | US7041297 Tumor antigen peptides originating in cyclophilin B |
| 05/09/2006 | US7041295 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 05/09/2006 | US7041291 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 05/09/2006 | US7041290 isolated monoclonal antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide of an epitope within or overlapping the amino acid sequence: SSDGLWNNNQTQLFLEHS; treating or preventing renal disease or injury |
| 05/09/2006 | US7041287 Comprises anticoagulant/thrombolytic agent for selective dissolution of fibrin clots |
| 05/09/2006 | US7041286 aspirin, magnesium, and nattokinase, and either niacin or nitroglycerine, especially in the form of a chewable tablet, nasal spray, or suppository |
| 05/09/2006 | US7041284 Recombinant adenoviral vector and method of use |